Home » EU

Thought Leadership

CBPartners’ EU Centre of Excellence has the global expertise to engage with business unit leaders on cross-market strategy. Our in-house local expertise and experience is paired with a strong network of healthcare decision-makers across the region.

Showing 5 of 23 posts
The 2021 German Federal Election:
September 30, 2021 | Infographics

The 2021 German Federal Election: What is the Future Outlook for Healthcare in Germany?

Following the 2021 German federal election, CBPartners highlights the top healthcare policy priorities from the winning party SDP and explores what a potential three-party coalition would look like for the country.

Regulators and HTA Bodies
August 24, 2021 | Blogs, Infographics

Drug Assessment Uncertainties: HTA Bodies vs. Regulators

A recent study of the review of new medicines by regulatory and HTA bodies has revealed areas of misalignment in their processes, highlighting unique challenges in the pathway to patient access.

Novel Combinations Double the Trouble
May 25, 2021 | Blogs

Novel Combinations: Double the Trouble

Launching a novel combination therapy provides a unique set of challenges and opportunities when seeking to achieve positive pricing and access outcomes. In this article, CBPartners reviewed the pricing and access outcomes from prior novel immuno-oncology combinations and have developed considerations for manufacturers developing strategies for their future pipeline.

eu in pills
April 14, 2020 | Blogs

The COVID-19 Pandemic: Pricing and Access Outlook for Future Innovative Drugs in Europe

Disruption in healthcare systems across Europe is rife due to the COVID-19 pandemic, with increasingly strained budgets, and shifting healthcare priorities.